Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs STLD✓SelectedUSD · STLDMRNA vs STLD performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs STLD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+772.1%
STLD return
+33.1%
Excess return
+739.0%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioSTLDExcessAlpha
1D-2.2%-5.6%+3.5%-5.7%
7D-12.7%-10.2%-2.5%-18.6%
30D-20.7%-16.9%-3.7%-30.6%
3M+46.3%-5.7%+52.0%+43.3%
6M+305.2%-9.4%+314.6%+244.6%
YTD+561.2%+22.5%+538.7%+393.1%
1Y+772.1%+36.0%+736.1%+535.2%
All+772.1%+33.1%+739.0%+535.2%

Cumulative growth

Daily Returns

Daily percentage return beside STLD.

Daily Out/Under-Performance

Portfolio return minus STLD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × STLD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded STLD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling